logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

New Stock News | Ruipai Pet Hospital's Hong Kong IPO prospectus is invalid.

date
22/06/2026
According to the Securities Times app, the Hong Kong IPO prospectus of Ruipai Pet Hospital Management Co., Ltd. (hereinafter referred to as Ruipai Pet Hospital) submitted on December 22, 2025, expired after 6 months on June 22, 2026. At the time of submission, China International Capital Corporation Limited acted as its exclusive sponsor.
Latest
4 m ago
The Pakistan KSE-100 index opened up 0.6%, reaching 180,440 points.
4 m ago
The US dollar against the Japanese yen fluctuated and rose, with the latest increase of 0.23% to 161.665.
6 m ago
Sihuan Pharmaceutical (00460.HK): Xuanzhu Biotech (02575.HK) announced the enrollment of the first patient in the Phase III clinical trial of anindazole sodium for new indications for the eradication of Helicobacter pylori.
6 m ago
Japan financed a record-breaking yen intervention in the foreign exchange market by selling US bonds.
7 m ago
AI company and SK Biopharmaceuticals have reached a research and development collaboration driven by artificial intelligence with a maximum value of 2.5 billion US dollars, receiving a maximum of 18 million US dollars in upfront payment and milestone payments in the near future.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.